- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
| Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
|---|---|---|---|---|---|---|
| Head, Portfolio Policy | East Hanover | USA | Corporate Affairs | Corporate | Communications & Public Affairs | Nov 12, 2024 |
| Senior Manager, Site Communications Basel | Basel (City) | Switzerland | Corporate Affairs | CTS | Communications & Public Affairs | Nov 11, 2024 |
| Director, Issue Advocacy & Portfolio Strategy | Washington, DC | USA | Corporate Affairs | Corporate | Communications & Public Affairs | Nov 11, 2024 |
| Associate Director, Issue Advocacy & Strategic Alliances | Washington, DC | USA | Corporate Affairs | Corporate | Communications & Public Affairs | Nov 11, 2024 |
| Directeur Affaires Publiques Aire Thérapeutique H/F | Paris Headquarter (Novartis Pharma S.A.S.) | France | International | Innovative Medicines | Communications & Public Affairs | Nov 08, 2024 |
| Director of Policy Communications and Media Relations, Europe | Basel (City) | Switzerland | Corporate Affairs | CTS | Communications & Public Affairs | Nov 07, 2024 |
| Communications & Patient Advocacy Manager | Selangor | Malaysia | Corporate Affairs | Innovative Medicines | Communications & Public Affairs | Nov 06, 2024 |
| Lead - Government Affairs | Delhi (Office) | India | International | Innovative Medicines | Communications & Public Affairs | Nov 05, 2024 |
| Director, Communications-Finance/Strategy & Growth Activation | Basel (City) | Switzerland | Corporate Affairs | CTS | Communications & Public Affairs | Nov 04, 2024 |
| Executive Director, Therapy Area Communications and Patient Advocacy | Basel (City) | Switzerland | Corporate Affairs | CTS | Communications & Public Affairs | Nov 04, 2024 |
| Director of Narrative Activation | Basel (City) | Switzerland | Corporate | CTS | Communications & Public Affairs | Nov 01, 2024 |
| Communication & Patient Advocacy Manager (f/m/d) | Vienna | Austria | International | CTS | Communications & Public Affairs | Oct 31, 2024 |
| Associate Director, Business Transformation & Engagement | Barcelona Gran Vía | Spain | Development | Innovative Medicines | Communications & Public Affairs | Oct 23, 2024 |
| Associate Director, Political Affairs & Insights | Washington, DC | USA | Corporate Affairs | Corporate | Communications & Public Affairs | Oct 22, 2024 |
| Government Affairs Manager | Moscow (City) | Russian Fed. | Corporate Affairs | Innovative Medicines | Communications & Public Affairs | Oct 22, 2024 |
| (Sr.) Public Affairs Manager | Taipei | Taiwan | International | Innovative Medicines | Communications & Public Affairs | Oct 20, 2024 |
| Comms & Engagement Manager | Amsterdam | Netherlands | Corporate Affairs | CTS | Communications & Public Affairs | Oct 16, 2024 |
| Associate Director, R&D Portfolio and Engagement - Communications | Cambridge (Massachusetts) | USA | Corporate Affairs | CTS | Communications & Public Affairs | Oct 08, 2024 |
| Public Affairs Manager | Ankara Gimat | Türkiye | International | Innovative Medicines | Communications & Public Affairs | Sep 13, 2024 |
| Patient Engagement Lead | İstanbul Kavacık | Türkiye | Corporate Affairs | CTS | Communications & Public Affairs | Sep 03, 2024 |
| Public Affairs Manager (m/f/d) | Berlin West (Non-Sales Force) (Novartis Pharma GmbH) | Germany | International | Innovative Medicines | Communications & Public Affairs | Jul 09, 2024 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى